Michael Wendt, PhD, appointed Co-Leader of Experimental Therapeutics Program
The following is reprinted from the January 30 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series….
The following is reprinted from the January 30 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series….